A pooled analysis of two randomized trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction. The late breaking study is presented in a Hot Line session today at ESC…
Read More
New ESC guidelines for diagnosis and treatment of heart failure published
The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chronic heart failure are published online today in European Heart Journal. This was the first ESC Guideline to include patients as full members of the…
Read More
New Pacing Method Shows Early Promise for Advanced Peripheral Conduction Disease
NEW YORK (Reuters Health) – Early results suggest that left bundle branch area pacing (LBBAP)-optimized cardiac resynchronization therapy (LOT-CRT) is feasible and safe, and offers greater electrical resynchronization compared with conventional biventricular pacing (BiV-CRT). LOT-CRT “could be an alternative option,…
Read More
Maintaining good hydration throughout life may reduce the risk of heart failure
Staying well hydrated throughout life could reduce the risk of developing heart failure, according to research presented at ESC Congress 2021. Our study suggests that maintaining good hydration can prevent or at least slow down the changes within the heart…
Read More
Increasing novel lncRNA in cardiomyocytes can inhibit the progression of heart failure
A research collaboration based in Kumamoto University (Japan) has identified a novel lncRNA, Caren, that is abundantly expressed in cardiomyocytes. They showed that it enhances energy production by increasing the number of mitochondria in cardiomyocytes, and inhibits activation of the…
Read More
People with intellectual disability more likely to die from COVID-19 than general population
Intellectual disability puts individuals at higher risk of dying earlier in life than the general population, for a variety of medical and institutional reasons. A new study from Jefferson Health examined how the COVID-19 pandemic has affected this group, which…
Read More
Higher blood pressure from childhood may put Black people at risk for congestive heart failure
Starting with early childhood, otherwise healthy Black people show signs of slightly diminished heart muscle strength and a slightly higher blood pressure than their white counterparts, factors which may put them on a course for early development of congestive heart…
Read More
Amlodipine/Valsartan/HCT Novartis
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VALSARTAN/AMLODIPINE/HCT NOVARTIS® 5/160/12.5, 5/160/25, 10/160/12.5, 10/160/25, 10/320/25 amlodipine besilate/valsartan/hydrochlorothiazide Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about AMLODIPINE/VALSARTAN/HCT NOVARTIS. It…
Read More
Naprosyn SR
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. NAPROSYN SR® pronounced nap-row-sin S-R contains the active ingredient naproxen Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about NAPROSYN SR…
Read More